http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014167436-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35bce0b8363dc3e87c11597734a15083
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2014-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dbbacc9851e35aaa9d89e46db743e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1e28063904d8ec8f725743c6c74d72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2588fe5c79c2d4ea44cb44b0fa9487d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d4ce37cbf0fe19b8dea6975eea4b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b67c08bad1fd1232253a865db1209f7
publicationDate 2015-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014167436-A3
titleOfInvention Sunitinib glucuronate salt & process for preparation thereof
abstract The present invention relates to novel pharmaceutically acceptable glucuronic acid addition salt of Sunitinib Formula (I) or its solvate thereof. The present invention further relates to the processes for preparation of the glucuronic acid addition salt of Sunitinib. Glucuronic acid addition salt of Sunitinib (I) prepared according to the process of the present invention is obtained as a solid material. The pharmaceutical compositions comprising glucuronic acid addition salt of Sunitinib or its solvate thereof may be useful as anti-cancer agent.
priorityDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010041134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011033472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011118477-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478

Total number of triples: 28.